Report cover image

Generics in France

Publisher MarketLine
Published Dec 18, 2025
Length 44 Pages
SKU # MTLN21050195

Description

Generics in France

Summary

Generics in France industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • A generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. Market value is evaluated at ex-factory prices. Market volume refers to the proportion of the total ethical pharmaceutical market in a country or region that is made up of generic drugs. Thus, it is a measure of the market share held by generics, rather than a direct measure of the total market volume. Regional volumes are calculated as averages of countries that comprise the region where volume data exists.
  • The French generics market recorded revenues of $5.0 billion in 2024, representing a compound annual growth rate (CAGR) of 6.7% between 2019 and 2024.
  • Market consumption volume increased with a CAGR of 1.3% between 2019 and 2024, reaching a total of 42.5% of total pharma volume in 2024.
  • In 2024, the revenue of the French generics market experienced an annual growth of 6.7%. The market’s growth is driven by the rising prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular conditions, increasing the demand for affordable, long-term medications.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in France
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in France
  • Leading company profiles reveal details of key generics market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the France generics market with five year forecasts by both value and volume
Reasons to Buy
  • What was the size of the France generics market by value in 2024?
  • What will be the size of the France generics market in 2029?
  • What factors are affecting the strength of competition in the France generics market?
  • How has the market performed over the last five years?
  • What are the main segments that make up France's generics market?

Table of Contents

44 Pages
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strategies of the leading players?
7.3. What are the recent developments in the market?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Ltd
8.2. Novartis AG
8.3. Sanofi
8.4. Les Laboratoires Servier SAS
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: France generics market value: $ million, 2019-24
Table 2: France generics market volume: % of total pharma volume, 2019-24
Table 3: France generics market geography segmentation: $ million, 2024
Table 4: France generics market value forecast: $ million, 2024-29
Table 5: France generics market volume forecast: % of total pharma volume, 2024-29
Table 6: Teva Pharmaceutical Industries Ltd: Key Facts
Table 7: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Ltd: Key Employees
Table 9: Novartis AG: Key Facts
Table 10: Novartis AG: Annual Financial Ratios
Table 11: Novartis AG: Key Employees
Table 12: Sanofi: Key Facts
Table 13: Sanofi: Annual Financial Ratios
Table 14: Sanofi: Key Employees
Table 15: Sanofi: Key Employees Continued
Table 16: Les Laboratoires Servier SAS: Key Facts
Table 17: Les Laboratoires Servier SAS: Key Employees
Table 18: France Size of Population (Million), 2020-24
Table 19: France Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 20: France GDP (Current Prices, $ Billion), 2020-24
Table 21: France Inflation, 2020-24
Table 22: France Consumer Price Index (Absolute), 2020-24
Table 23: France Exchange Rate, 2019-24
List of Figures
Figure 1: France generics market value: $ million, 2019-24
Figure 2: France generics market volume: % of total pharma volume, 2019-24
Figure 3: France generics market geography segmentation: % share, by value, 2024
Figure 4: France generics market value forecast: $ million, 2024-29
Figure 5: France generics market volume forecast: % of total pharma volume, 2024-29
Figure 6: Forces driving competition in the generics market in France, 2024
Figure 7: Drivers of buyer power in the generics market in France, 2024
Figure 8: Drivers of supplier power in the generics market in France, 2024
Figure 9: Factors influencing the likelihood of new entrants in the generics market in France, 2024
Figure 10: Factors influencing the threat of substitutes in the generics market in France, 2024
Figure 11: Drivers of degree of rivalry in the generics market in France, 2024

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us